Delray Beach, FL , Jan. 12, 2026 (GLOBE NEWSWIRE) -- The global pain management devices market, valued at US$3491.0 million in 2023, stood at US$3,768.6 million in 2024 and is projected to advance at ...
According to a new market research report "Pain Management Devices Market by Device Type (Neurostimulation, SCS, TENS, RF Ablation, Infusion Pumps), Application (Cancer, Neuropathy, Musculoskeletal, ...
Add Yahoo as a preferred source to see more of our stories on Google. LAFAYETTE, Ind. − A Lafayette pain management clinic became the first in the nation to test a noninvasive device that stimulates ...
DUBLIN--(BUSINESS WIRE)--The "Pain Management Devices Market - A Global and Regional Analysis: Focus on Type, Application, End User, and Country - Analysis and Forecast, 2024-2034" report has been ...
According to a new market report published by Transparency Market Research "Pain Management Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023", the global ...
Demand for pain management devices is climbing worldwide, fueled by several major trends. As chronic disease rates soar, the need for effective, drug-free pain solutions has grown more pressing. At ...
Curapod is a wearable therapy device designed for at-home muscle pain management. The device combines electrical stimulation ...
The global pain management devices market is projected to expand at a compound annual growth rate (CAGR) of approximately 9% over the forecast period, driven by the rising incidence of chronic ...
Neuros Medical, a medical device company in Willoughby, Ohio, announced the completion of its implantable generator for use in chronic pain applications, according to a Fort Mill Times report. Altius, ...
Rising demand for chronic pain management in home care settings is a significant factor driving global pain management devices market revenue growth VANCOUVER, Canada - April 20, 2023 — The Global ...
The global pain management devices market is projected to expand at a compound annual growth rate (CAGR) of approximately 9% over the forecast period, driven by the rising incidence of chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results